Actome GmbH and QIAGEN announce commercial partnership
Actome GmbH, a life-science start-up company from the University of Freiburg and Hahn-Schickard, Germany has signed a li…
Actome GmbH, a life-science start-up company from the University of Freiburg and Hahn-Schickard, Germany has signed a li…
Q1 2021 net sales rise 52% (48% CER) to $567.2 million, exceeds outlook for at least 45% CER growth; adj. EPS up 94% to…
NeuMoDx™ Flu A-B/RSV/SARS-CoV-2 Vantage Test receives Emergency Use Authorization by FDA The 4-plex test utilizes the hi…
• U.S. FDA approves therascreen BRAF V600E RGQ PCR assay as companion diagnostic • Test will help identify patients elig…
. • QIAstat-Dx syndromic testing system can differentiate novel coronavirus from 20 other respiratory targets • Requires…
Goal to reach global capacity for RNA nucleic extraction workflows for over 10 million patient tests a month by end of J…
First syndromic testing solution to get U.S. agency’s development support in novel coronavirus response QIAstat-Dx R…
. Expands specialty diagnostics portfolio with attractive molecular diagnostics capabilities, including infectious di…
. QIAstat-Dx Respiratory 2019-nCoV Panel rapidly differentiates novel coronavirus from 21 other pathogens implicated i…
• QIAGEN and Amgen to develop tissue-based therascreen® test, paired with investigational treatment AMG 510, to identify…